Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT

European Journal of Radiology

Volumn 73, Issue 2, 2010, Pages 324-328

  Dirisamer, Albert ^a,b   Halpern, Benjamin S ^b   Flöry, Daniel ^c   Wolf, Florian ^b   Beheshti, Mohsen ^a   Mayerhoefer, Marius E ^b   Langsteger, Werner ^a  

^a St Vincent's Hospital   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Colorectal cancer; Contrast enhancement; PET CT

Indexed keywords

ADDED VALUES; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTRAST-ENHANCED; CONTRAST-ENHANCED CT; DIAGNOSTIC VALUE; FALSE POSITIVE; MEAN AGES; ONE STEP;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYSTEMS INTEGRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76349124860     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.10.030     Document Type: Article

References (27)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 March (3) (2007) 581-592
2. Benson III A.B. The hope for today-the promise for tomorrow: will oncologists meet the challenge?. J Clin Oncol 25 (2007) 2156-2158
3. Desch C.E., Benson III A.B., Somerfield M.R., et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23 (2005) 8512-8519
4. Ariyan C.E., and Salem R.R. Evolution in the treatment of metastatic colorectal carcinoma of the liver. World J Gastroenterol 12 (2006) 3253-3258
5. Fernandes L.C., Kim S.B., Saad S.S., and Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol 12 (2006) 3891-3894
6. Flamen P., Stroobants S., Van Cutsem E., et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer. J Clin Oncol 17 March (3) (1999) 894-901
7. Keogan M.T., Lowe V.J., Baker M.E., McDermott V.G., Lyerly H.K., and Coleman R.E. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging 22 May-June (3) (1997) 332-337
8. Delbeke D., Vitola J.V., Sandler M.P., et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38 August (8) (1997) 1196-1201
9. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 June 19 (25) (2003) 2500-2507
10. Antoch G., Vogt F.M., Freudenberg L.S., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290 December 24 (24) (2003) 3199-3206
11. Jadvar H., Henderson R.W., and Conti P.S. 2-Deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol 8 (2006) 193-200
12. Mochiki E., Kuwano H., Katoh H., Asao T., Oriuchi N., and Endo K. Evaluation of 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography for gastric cancer. World J Surg 28 (2004) 247-253
13. Gearhart S.L., Frassica D., Rosen R., Choti M., Schulick R., and Wahl R. Improved Staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13 (2006) 397-404
14. Ito K., Kato T., Tadokoro M., et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 182 (1992) 549-552
15. Cantwell C.P., Setty B.N., Holalkere N., Sahani D.V., Fischman A.J., and Blake M.A. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. J Comput Assist Tomogr 32 September-October (5) (2008) 738-744
16. Groves A.M., Wishart G.C., Shastry M., et al. Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging (2008) September 26
17. Kitajima K., Murakami K., Yamasaki E., et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging 35 October (10) (2008) 1912-1920
18. Dirisamer A., Schima W., Heinisch M., et al. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol (2008) January 11
19. Soyka J.D., Veit-Haibach P., Strobel K., et al. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?. J Nucl Med 49 March (3) (2008) 354-361
20. Chen L.B., Tong J.L., Song H.Z., Zhu H., and Wang Y.C. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 13 October 7 (37) (2007) 5025-5029
21. Selzner M., Hany T.F., Wildbrett P., McCormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 240 (2004) 1027-1034
22. Veit-Haibach P., Kuehle C.A., Beyer T., et al. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 296 (2006) 2590-2600
23. Hoyert D.L., Kung H.C., and Smith B.L. Deaths: preliminary data for 2003. Natl Vital Stat Rep 53 (2005) 1-48
24. National Center of Health Statistics. Health, US, 2004. With chartbook on trends in the health of Americans (2004), National Center of Health Statistics, Hyattsville, MD
25. Kim J.H., Czernin J., Allen-Auerbach M.S., et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 46 April (4) (2005) 587-595
26. Alberts S., and Poston G.J. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer. Colorectal Dis 5 Suppl. S3 (2003) 20-28
27. Poston G.J. Radiofrequency ablation of colorectal liver metastases: where are we really going?. J Clin Oncol 23 (2005) 1342-1344